HomeCompareNNCHY vs ARCC

NNCHY vs ARCC: Dividend Comparison 2026

NNCHY yields 3.07% · ARCC yields 10.65%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NNCHY wins by $212.60M in total portfolio value· pulled ahead in Year 2
10 years
NNCHY
NNCHY
● Live price
3.07%
Share price
$38.16
Annual div
$1.17
5Y div CAGR
95.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$212.63M
Annual income
$197,266,587.95
Full NNCHY calculator →
ARCC
Ares Capital Corporation
● Live price
10.65%
Share price
$18.02
Annual div
$1.92
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.5K
Annual income
$1.14
Full ARCC calculator →

Portfolio growth — NNCHY vs ARCC

📍 NNCHY pulled ahead of the other in Year 2

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNNCHYARCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NNCHY + ARCC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NNCHY pays
ARCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NNCHY
Annual income on $10K today (after 15% tax)
$260.61/yr
After 10yr DRIP, annual income (after tax)
$167,676,599.76/yr
ARCC
Annual income on $10K today (after 15% tax)
$905.66/yr
After 10yr DRIP, annual income (after tax)
$0.97/yr
At 15% tax rate, NNCHY beats the other by $167,676,598.79/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NNCHY + ARCC for your $10,000?

NNCHY: 50%ARCC: 50%
100% ARCC50/50100% NNCHY
Portfolio after 10yr
$106.33M
Annual income
$98,633,294.54/yr
Blended yield
92.76%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ARCC right now

NNCHY
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
7.9
Piotroski
9/9
ARCC
Analyst Ratings
24
Buy
7
Hold
Consensus: Buy
Price Target
$21.88
+21.4% upside vs current
Range: $21.00 — $23.00
Altman Z
0.8
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NNCHY buys
0
ARCC buys
0
No recent congressional trades found for NNCHY or ARCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNNCHYARCC
Forward yield3.07%10.65%
Annual dividend / share$1.17$1.92
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR95.7%-50%
Portfolio after 10y$212.63M$24.5K
Annual income after 10y$197,266,587.95$1.14
Total dividends collected$211.46M$1.1K
Payment frequencyquarterlyquarterly
SectorStockBDC
Analyst consensusBuyBuy

Year-by-year: NNCHY vs ARCC ($10,000, DRIP)

YearNNCHY PortfolioNNCHY Income/yrARCC PortfolioARCC Income/yrGap
1$11,300$600.01$11,373$532.74$73.00ARCC
2← crossover$13,331$1,240.06$12,608$279.46+$723.00NNCHY
3$16,940$2,675.69$13,809$142.90+$3.1KNNCHY
4$24,344$6,218.56$15,042$72.20+$9.3KNNCHY
5$42,393$16,344.90$16,341$36.27+$26.1KNNCHY
6$97,419$52,058.22$17,732$18.18+$79.7KNNCHY
7$323,036$218,797.85$19,231$9.10+$303.8KNNCHY
8$1,672,608$1,326,958.99$20,851$4.55+$1.65MNNCHY
9$14,355,990$12,566,300.15$22,605$2.28+$14.33MNNCHY
10$212,627,498$197,266,587.95$24,504$1.14+$212.60MNNCHY

NNCHY vs ARCC: Complete Analysis 2026

NNCHYStock

Nissan Chemical Corporation engages in the chemicals, performance materials, agricultural chemicals, and pharmaceuticals businesses in Japan and internationally. Its chemical products include MELAMINE, an adhesive agent; high purity chemicals; AdBlue, an urea solution; ammonia, sulfuric, and nitric acid; TEPIC, an epoxy compound; Melamine Cyanurate, a salt of melamine and iso cyanuric acid; Nissan Reishi, a health food; phenylphosphonic acid; HI-LITE, a chlorinated isocyanulate; OPTBEADS, a melamine-formaldehyde resin and silica; and FINEOXOCOL, a saturated fatty alcohol and acid. The company also offers performance materials comprising display, semiconductor, and inorganic materials; agricultural chemicals, such as herbicides, insecticides, fungicides, etc. for use on agricultural land, as well as in golf courses and parks; and drug substances for antiparasite drugs for animals. In addition, it provides pharmaceutical products, such as LIVALO, a cholesterol reduction agent; LANDEL and FINTE, a dual type calcium antagonist that blocks calcium channels; and custom manufacturing and process researching services for pharmaceutical ingredients. Further, the company develops healthcare, information and communication materials, and environmental and energy materials. The company was formerly known as Nissan Chemical Industries, Ltd. and changed its name to Nissan Chemical Corporation in July 2018. Nissan Chemical Corporation was founded in 1887 and is headquartered in Tokyo, Japan.

Full NNCHY Calculator →

ARCCBDC

Ares Capital Corporation is a business development company specializing in acquisition, recapitalization, mezzanine debt, restructurings, rescue financing, and leveraged buyout transactions of middle market companies. It also makes growth capital and general refinancing. It prefers to make investments in companies engaged in the basic and growth manufacturing, business services, consumer products, health care products and services, and information technology service sectors. The fund will also consider investments in industries such as restaurants, retail, oil and gas, and technology sectors. It focuses on investments in Northeast, Mid-Atlantic, Southeast and Southwest regions from its New York office, the Midwest region, from the Chicago office, and the Western region from the Los Angeles office. The fund typically invests between $20 million and $200 million and a maximum of $400 million in companies with an EBITDA between $10 million and $250 million. It makes debt investments between $10 million and $100 million The fund invests through revolvers, first lien loans, warrants, unitranche structures, second lien loans, mezzanine debt, private high yield, junior capital, subordinated debt, and non-control preferred and common equity. The fund also selectively considers third-party-led senior and subordinated debt financings and opportunistically considers the purchase of stressed and discounted debt positions. The fund prefers to be an agent and/or lead the transactions in which it invests. The fund also seeks board representation in its portfolio companies.

Full ARCC Calculator →
📬

Get this NNCHY vs ARCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NNCHY vs SCHDNNCHY vs JEPINNCHY vs ONNCHY vs KONNCHY vs MAINNNCHY vs HTGCNNCHY vs GBDCNNCHY vs ORCC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.